What is the ticker symbol for AIkido Pharma?

AIkido Pharma trades under the ticker AIKI on NASDAQ.

What sector does AIkido Pharma operate in?

AIkido Pharma is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze AIKI in a portfolio?

PortView shows AIKI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

AIkido Pharma (AIKI) Stock Analysis

NASDAQHealthcareBiotechnology

$3.56+0.85%

1-year price historyRange $3.42 – $10.88

52-week range$3.56

$0.29$7.27

What AIkido Pharma does

AIkido Pharma Inc., established in 1967 and headquartered in New York, New York, is a biotechnology company primarily engaged in pioneering small-molecule anti-cancer treatments. The firm, which operated as Spherix Incorporated until its rebranding in March 2021, possesses a robust therapeutic pipeline addressing various malignancies, including prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. Key drug candidates in its development portfolio include DHA-dFdC, targeting pancreatic cancer, and KPC34, a small molecule designed for the treatment of both AML and acute lymphoblastic leukemia. Furthermore, AIkido Pharma Inc. is advancing an antiviral platform engineered to hinder the proliferation of numerous viruses, such as the influenza virus, Ebolavirus, Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. The company holds strategic license agreements with several academic and research institutions, including the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences.

Key metrics

Market cap

$19.53M

P/E (TTM)

0.00

EPS (TTM)

$0.00

Beta

0.00

Dividend yield

44.36%

Revenue / share

$5.87

50-day avg

$4.23

200-day avg

$4.33

52-week high

$7.27

52-week low

$0.29

CEO

Anthony C. Hayes

ETFs linked to AIKI

Broad-market and Healthcare sector ETFs an investor holding AIkido Pharma is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how AIKI fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze AIKI in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for AIkido Pharma?: AIkido Pharma trades under the ticker AIKI on NASDAQ.
Which exchange is AIKI listed on?: AIKI is listed on NASDAQ.
What sector does AIkido Pharma operate in?: AIkido Pharma is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze AIKI in a portfolio?: PortView shows AIKI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.